Literature DB >> 30936201

Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network.

Anan Yu1, Susan G Fox1, Annalisa Cavallini2, Caroline Kerridge2, Michael J O'Neill2, Joanna Wolak2, Suchira Bose2, Richard I Morimoto3.   

Abstract

Tauopathies are a diverse class of neurodegenerative diseases characterized by the formation of insoluble tau aggregates and the loss of cellular function and neuronal death. Tau inclusions have been shown to contain a number of proteins, including molecular chaperones, but the consequences of these entrapments are not well established. Here, using a human cell system for seeding-dependent tau aggregation, we demonstrate that the molecular chaperones heat-shock cognate 71-kDa protein (HSC70)/heat-shock protein 70 (HSP70), HSP90, and J-domain co-chaperones are sequestered by tau aggregates. By employing single-cell analysis of protein-folding and clathrin-mediated endocytosis, we show that both chaperone-dependent cellular activities are significantly impaired by tau aggregation and can be reversed by treatment with small-molecule regulators of heat-shock transcription factor 1 (HSF1) proteostasis that induce the expression of cytosolic chaperones. These results reveal that the sequestration of cytoplasmic molecular chaperones by tau aggregates interferes with two arms of the proteostasis network, likely having profound negative consequences for cellular function.
© 2019 Yu et al.

Entities:  

Keywords:  Clathrin-mediated endocytosis; HSC70; HSP27; HSP70; Tau protein (Tau); chaperone; chaperone competition; heat-shock protein (HSP); heat-shock protein 90 (Hsp90); protein aggregation

Mesh:

Substances:

Year:  2019        PMID: 30936201      PMCID: PMC6514629          DOI: 10.1074/jbc.RA119.007527

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  89 in total

1.  Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD.

Authors:  E C Beattie; R C Carroll; X Yu; W Morishita; H Yasuda; M von Zastrow; R C Malenka
Journal:  Nat Neurosci       Date:  2000-12       Impact factor: 24.884

Review 2.  Unfolding the role of protein misfolding in neurodegenerative diseases.

Authors:  Claudio Soto
Journal:  Nat Rev Neurosci       Date:  2003-01       Impact factor: 34.870

3.  Tubulin requires tau for growth onto microtubule initiating sites.

Authors:  G B Witman; D W Cleveland; M D Weingarten; M W Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

4.  Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo.

Authors:  Sarah K Kaufman; David W Sanders; Talitha L Thomas; Allison J Ruchinskas; Jaime Vaquer-Alicea; Apurwa M Sharma; Timothy M Miller; Marc I Diamond
Journal:  Neuron       Date:  2016-10-27       Impact factor: 17.173

5.  Identification of polypeptides in neurofibrillary tangles and total homogenates of brains with Alzheimer's disease by tandem mass spectrometry.

Authors:  Benito Minjarez; María Luz Valero Rustarazo; Manuel M Sanchez del Pino; Arturo González-Robles; Jorge A Sosa-Melgarejo; Jose Luna-Muñoz; Raul Mena; Juan Pedro Luna-Arias
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

6.  Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA.

Authors:  Andreas C Woerner; Frédéric Frottin; Daniel Hornburg; Li R Feng; Felix Meissner; Maria Patra; Jörg Tatzelt; Matthias Mann; Konstanze F Winklhofer; F Ulrich Hartl; Mark S Hipp
Journal:  Science       Date:  2015-12-03       Impact factor: 47.728

Review 7.  Tau in physiology and pathology.

Authors:  Yipeng Wang; Eckhard Mandelkow
Journal:  Nat Rev Neurosci       Date:  2015-12-03       Impact factor: 34.870

8.  Distinct tau prion strains propagate in cells and mice and define different tauopathies.

Authors:  David W Sanders; Sarah K Kaufman; Sarah L DeVos; Apurwa M Sharma; Hilda Mirbaha; Aimin Li; Scarlett J Barker; Alex C Foley; Julian R Thorpe; Louise C Serpell; Timothy M Miller; Lea T Grinberg; William W Seeley; Marc I Diamond
Journal:  Neuron       Date:  2014-05-22       Impact factor: 17.173

9.  A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity.

Authors:  Zeshan Ahmed; Jane Cooper; Tracey K Murray; Katya Garn; Emily McNaughton; Hannah Clarke; Samira Parhizkar; Mark A Ward; Annalisa Cavallini; Samuel Jackson; Suchira Bose; Florence Clavaguera; Markus Tolnay; Isabelle Lavenir; Michel Goedert; Michael L Hutton; Michael J O'Neill
Journal:  Acta Neuropathol       Date:  2014-02-16       Impact factor: 17.088

10.  Spatial sequestration of misfolded proteins by a dynamic chaperone pathway enhances cellular fitness during stress.

Authors:  Stéphanie Escusa-Toret; Willianne I M Vonk; Judith Frydman
Journal:  Nat Cell Biol       Date:  2013-09-15       Impact factor: 28.824

View more
  18 in total

Review 1.  Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies.

Authors:  Che-Wei Chang; Eric Shao; Lennart Mucke
Journal:  Science       Date:  2021-02-26       Impact factor: 47.728

2.  Targeting DNA topoisomerases or checkpoint kinases results in an overload of chaperone systems, triggering aggregation of a metastable subproteome.

Authors:  Suzanne L Dekker; Joris C J van der Lienden; Wouter Huiting; Rafaella Mergener; Maiara K Musskopf; Gabriel V Furtado; Emma Gerrits; David Coit; Mehrnoosh Oghbaie; Luciano H Di Stefano; Hein Schepers; Maria A W H van Waarde-Verhagen; Suzanne Couzijn; Lara Barazzuol; John LaCava; Harm H Kampinga; Steven Bergink
Journal:  Elife       Date:  2022-02-24       Impact factor: 8.140

Review 3.  Molecular mechanisms of amyloid formation in living systems.

Authors:  Tessa Sinnige
Journal:  Chem Sci       Date:  2022-05-17       Impact factor: 9.969

Review 4.  Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.

Authors:  Tessa Sinnige; Anan Yu; Richard I Morimoto
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 5.  Epileptic Mechanisms Shared by Alzheimer's Disease: Viewed via the Unique Lens of Genetic Epilepsy.

Authors:  Jing-Qiong Kang
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

Review 6.  Small Heat Shock Proteins, Big Impact on Protein Aggregation in Neurodegenerative Disease.

Authors:  Jack M Webster; April L Darling; Vladimir N Uversky; Laura J Blair
Journal:  Front Pharmacol       Date:  2019-09-18       Impact factor: 5.810

Review 7.  Tau at the interface between neurodegeneration and neuroinflammation.

Authors:  Alessandro Didonna
Journal:  Genes Immun       Date:  2020-10-03       Impact factor: 2.676

8.  Hsp22 with an N-Terminal Domain Truncation Mediates a Reduction in Tau Protein Levels.

Authors:  Jack M Webster; April L Darling; Taylor A Sanders; Danielle M Blazier; Yamile Vidal-Aguiar; David Beaulieu-Abdelahad; Drew G Plemmons; Shannon E Hill; Vladimir N Uversky; Paula C Bickford; Chad A Dickey; Laura J Blair
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

9.  α-Synuclein modulates tau spreading in mouse brains.

Authors:  Fares Bassil; Emily S Meymand; Hannah J Brown; Hong Xu; Timothy O Cox; Shankar Pattabhiraman; Chantal M Maghames; Qihui Wu; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Exp Med       Date:  2021-01-04       Impact factor: 14.307

10.  A combinatorial native MS and LC-MS/MS approach reveals high intrinsic phosphorylation of human Tau but minimal levels of other key modifications.

Authors:  Friedel Drepper; Jacek Biernat; Senthilvelrajan Kaniyappan; Helmut E Meyer; Eva Maria Mandelkow; Bettina Warscheid; Eckhard Mandelkow
Journal:  J Biol Chem       Date:  2020-10-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.